Corebridge Financial’s Lyra Therapeutics LYRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-474	Closed	-$2.99K	–	1586
2025 Q1	$2.99K	Sell	474 -7	-1%	-$44	﹤0.01%	3007
2024 Q4	$4.97K	Sell	481 -37	-7%	-$382	﹤0.01%	3020
2024 Q3	$6.65K	Sell	518 -3	-0.6%	-$39	﹤0.01%	3030
2024 Q2	$7.47K	Buy	+521	New	+$7.47K	﹤0.01%	3041